Diagnosis of Hepatitis C Virus Infection by Enzyme-linked Immunosorbent Assay and Reverse Transcriptase-Nested Polymerase Chain Reaction: A Comparative Evaluation

Department of Biochemistry, Genetic Engineering and Biotechnology Research Division, National Research Center, Dokki, Giza, Egypt.
International Union of Biochemistry and Molecular Biology Life (Impact Factor: 3.14). 06/2011; 63(6):430-4. DOI: 10.1002/iub.469
Source: PubMed


Hepatitis C virus is one of the main causes of chronic hepatitis in developing countries. The current study was to evaluate the efficacy of the enzyme-linked immunosorbent assay third generation (ELISA-3) for detection of antibodies to hepatitis C virus (anti-HCV) in comparison with reverse transcriptase-nested polymerase chain reaction (RT-nested PCR) to detect HCV RNA for the diagnosis of hepatitis C virus. Serum samples were collected from 151 chronic hepatitis C patients and 50 healthy individuals. All samples were tested for anti-HCV antibodies using ELISA-3 and HCV RNA by RT-nested PCR. Of the 151,120 (78.9%) were found to be seropositive by ELISA-3, and 148 (98%) patients were HCV RNA positive, 118 (78.1%) were positives for both, 30 (19.9%) were positive for ELISA-3 and negative for RT-PCR, and 2 cases (1.3%) were positive for RT-nested PCR and negative for ELISA-3. The sensitivity and the specificity for the detection of HCV were absolute when the two techniques were combined. In conclusion, ELISA-3 is a suitable assay for routine screening for anti-HCV. RT-nested PCR for HCV is a value for the early detection of viremic, anti-HCV negative cases; this may be of importance in treatment of hepatitis C.

Download full-text


Available from: Menha Swellam, Nov 27, 2014
  • Source
    • "Virological tests have become essentials in all the main aspects of HCV clinical management, including diagnosis, treatment planning, and response-to-treatment evaluation. These tests include: (a) ELISA serological tests to detect HCV antibodies, (b) NAT (nucleic acid amplification techniques) assays to detect and quantify HCV RNA, and (c) genotyping [9]. Since serological assays cannot distinguish between patients with active infection and those who have acquired immunity, NAT tests for HCV are commonly used as a marker of current infection, as predictor of infectivity, and to monitor the efficacy of antiviral therapy [10] [11]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) is one of the main causes of chronic liver disease worldwide. The diagnosis and monitoring of HCV infection is a crucial need in the clinical management. The conventional diagnostic technologies are challenged when trying to address molecular diagnostics, especially because they require a complex and time-consuming sample preparation phase. Here, a new concept based on surface functionalization was applied to viral RNA purification: first of all polydimethylsiloxane (PDMS) flat surfaces were modified to hold RNA adsorption. After a careful chemical and morphological analysis of the modified surfaces, the functionalization protocols giving the best RNA adsorbing surfaces were applied to PDMS microdevices. The functionalized microdevices were then used for RNA purification from HCV infected human plasma samples. RNA purification and RT were successfully performed in the same microdevice chamber, saving time of analysis, reagents, and labor. The PCR protocol for HCV cDNA amplification was also implemented in the microdevice, demonstrating that the entire process of HCV analysis, from plasma to molecular readout, could be performed on-chip. Not only HCV but also other microdevice-based viral RNA detection could therefore result in a successful Point-of-Care (POC) diagnostics for resource-limited settings. Copyright © 2015 Elsevier B.V. All rights reserved.
    Biophysical chemistry 06/2015; DOI:10.1016/j.bpc.2015.06.005 · 1.99 Impact Factor
  • Source
    • "In previous studies, virus concentrations up to 10 2 virus-copies/mL were detected using RT-PCR compared to 10 5 virus-copies/mL with other methods [33]. The widespread use of RT-PCR for NV detection can be attributed to its superior sensitivity compared to other methods [35] [36]. For example, it is the recommended method for detection of NV in contaminated water, in which NV commonly exists at 4.91× 10 2 –3.51 ×10 3 copies/mL [29]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Norovirus (NV) is a major viral pathogen that causes nonbacterial acute gastroenteritis and outbreaks of food-borne disease. The genotype of NV most frequently responsible for NV outbreaks is GII.4, which accounts for 60-80% of cases. Moreover, original and new NV variant types have been continuously emerging, and their emergence is related to the recent global increase in NV infection. In this study, we developed advanced primer sets (NKI-F/R/F2, NKII-F/R/R2) for the detection of NV, including the variant types. The new primer sets were compared with conventional primer sets (GI-F1/R1/F2, SRI-1/2/3, GII-F1/R1/F2, and SRII-1/2/3) to evaluate their efficiency when using clinical and environmental samples. Using reverse transcription polymerase chain reaction (RT-PCR) and seminested PCR, NV GI and GII were detected in 91.7% (NKI-F/R/F2), 89.3% (NKII-F/R/R2), 54.2% (GI-F1/R1/F2), 52.5% (GII-F1/R1/F2), 25.0% (SRI-1/2/3), and 32.2% (SRII-1/2/3) of clinical and environmental specimens. Therefore, our primer sets perform better than conventional primer sets in the detection of emerged types of NV and could be used in the future for epidemiological diagnosis of infection with the virus.
    BioMed Research International 01/2015; 2015:103052. DOI:10.1155/2015/103052 · 1.58 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C is one of the most common blood-borne diseases causing significant morbidity and mortality globally. This study was designed to evaluate any correlation between 3rd generations ELISA positivity for anti-HCV antibody plus elevated ALT levels with Real-time PCR based detection among various categories of patients attending Khyber Teaching Hospital Peshawar. Total 160 serum samples were collected from clinically HCV positive individuals. All samples were tested for anti-HCV antibodies and HCV RNA using 3rd generation ELISA and real time PCR. Our analysis of all 160 positive samples indicated that 158 (98.75%) had anti-HCV antibodies in their sera (Male, 82; Female, 76), while 2 subjects (a male and a female) were negative for anti-HCV using third generation ELISA. Real-time PCR analysis further revealed that 100 subjects (62.5%) had active HCV infection while the remaining 60 (37.5%) subjects did not have HCV RNA in their sera. Our study indicates that seropositivity does not reveal the presence of active HCV infection as it may be due to the self-limiting nature of the disease or due to false positivity, which is often experienced in case of antibodies based detection.
    Pakistan journal of zoology 01/2013; 45(6):1579-1584. · 0.40 Impact Factor
Show more